Big smiles while raising funds and awareness! Walkers pose for a photo at a previous APDA Optimism Walk. "The more funds we raise at each Optimism Walk, the more people we can help every day through much-needed support groups, exercise classes designed specifically for people with PD, educational conferences, and so much more.” -- Leslie A. … [Read more...] about American Parkinson Disease Association (APDA) Kicks-Off 2023 National Optimism Walk Series
New WORX Nitro 20-volt Three-Speed Impact Driver Electronically Improves Keypad Speed and Impact Rate
WORX Nitro 20V 3-Speed Impact Driver CHARLOTTE, N.C. (PRWEB) March 28, 2023 The new WORX® Nitro™ 20V 3-Speed Impact Driver features digital keypad to change speed and impact rate electronically. Outfitted with a … [Read more...] about New WORX Nitro 20-volt Three-Speed Impact Driver Electronically Improves Keypad Speed and Impact Rate
NAMI Metropolitan Baltimore Elevates Mental Health Conversation with LOUDER Event
This year’s LOUDER honorees and speakers are Monica Mitchell, Senior Vice President of the Wells Fargo Foundation, and Brown Advisory, accepted by Michael Hankin, President & CEO. "284,000 adults in Baltimore City and County have a mental health condition–that’s the equivalent of four full Baltimore Ravens stadiums." … [Read more...] about NAMI Metropolitan Baltimore Elevates Mental Health Conversation with LOUDER Event
OneCause Releases Innovative Online Fundraising Experience for Nonprofits
The modern, flexible tools are part of the integrated OneCause Fundraising Platform and include online giving sites with personal fundraising page capabilities to foster donor engagement and offer a supporter-driven experience.INDIANAPOLIS, March 27, 2023 /PRNewswire/ -- OneCause, a leading provider of digital fundraising technology, today announced the launch of new online … [Read more...] about OneCause Releases Innovative Online Fundraising Experience for Nonprofits
NeuroSense Therapeutics & Massachusetts General Hospital’s NeuroEpigenetics Lab to Collaborate on Elucidating Neurotherapeutic Effects of PrimeC in ALS USA – English Israel – English
In vitro studies to test the effects of PrimeC on key pathways involved in ALS including TDP-43 accumulation, autophagy defects, mitochondrial dysfunction, and oxidative stress Preliminary results from this collaboration will be presented by Dr. Zimri at the upcoming AD/PD 2023 Advances in Science & Therapy Conference PrimeC is currently being evaluated in PARADIGM, a … [Read more...] about NeuroSense Therapeutics & Massachusetts General Hospital’s NeuroEpigenetics Lab to Collaborate on Elucidating Neurotherapeutic Effects of PrimeC in ALS USA – English Israel – English